Paper41488674
PSMD14 drives lung adenocarcinoma progression through HMMR stabilization and dual activation of TGF-β/Smad and PI3K/AKT/mTOR signaling.
Chen R and 2 others. Front Immunol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. PSMD14 drives lung adenocarcinoma progression through HMMR stabilization and dual activation of TGF-β/Smad and PI3K/AKT/mTOR signaling. Papers, record 41488674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41488674
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PSMD14 drives lung adenocarcinoma progression through HMMR stabilization and dual activation of TGF-β/Smad and PI3K/AKT/mTOR signaling.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Adenocarcinoma of Lung | Major topic |
| Proteasome Endopeptidase Complex | Major topic |
| Humans | |
| Proto-Oncogene Proteins c-akt | |
| Signal Transduction | |
| TOR Serine-Threonine Kinases | |
| Animals | |
| Transforming Growth Factor beta | |
| Mice | |
| Disease Progression | |
| Phosphatidylinositol 3-Kinases | |
| Cell Line, Tumor | |
| Smad Proteins | |
| Female | |
| Cell Proliferation | |
| Gene Expression Regulation, Neoplastic | |
| Xenograft Model Antitumor Assays |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37633647 | Ubiquitination and deubiquitination: Implications on cancer therapy. | Biochim Biophys Acta Gene Regul Mech | 2023 | https://conductscience.org/library/papers/37633647 | PubMed |
| 2 | 36241058 | Novel insights into the non-canonical roles of PSMD14/POH1/Rpn11 in proteostasis and in the modulation of cancer progression. | Cell Signal | 2023 | https://conductscience.org/library/papers/36241058 | PubMed |
| 3 | 31454018 | Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. | JAMA | 2019 | https://conductscience.org/library/papers/31454018 | PubMed |
| 4 | 37479810 | The global burden of lung cancer: current status and future trends. | Nat Rev Clin Oncol | 2023 | https://conductscience.org/library/papers/37479810 | PubMed |
| 5 | 39929409 | Role of ubiquitination-driven metabolisms in oncogenesis and cancer therapy. | Semin Cancer Biol | 2025 | https://conductscience.org/library/papers/39929409 | PubMed |
| 6 | 33456565 | Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness. | Theranostics | 2021 | https://conductscience.org/library/papers/33456565 | PubMed |
| 7 | 34916492 | Targeting PI3K/Akt signal transduction for cancer therapy. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34916492 | PubMed |
| 8 | 40537889 | Ubiquitination in cancer: mechanisms and therapeutic opportunities. | Cancer Commun (Lond) | 2025 | https://conductscience.org/library/papers/40537889 | PubMed |
| 9 | 35405117 | Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1. | Exp Cell Res | 2022 | https://conductscience.org/library/papers/35405117 | PubMed |
| 10 | 39817679 | Cancer statistics, 2025. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/39817679 | PubMed |
| 11 | 35393420 | Modification of BRCA1-associated breast cancer risk by HMMR overexpression. | Nat Commun | 2022 | https://conductscience.org/library/papers/35393420 | PubMed |
| 12 | 36183999 | TGF-β in developmental and fibrogenic EMTs. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/36183999 | PubMed |
| 13 | 38061486 | POH1 induces Smad3 deubiquitination and promotes lung cancer metastasis. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38061486 | PubMed |
| 14 | 32226511 | Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance. | J Cancer | 2020 | https://conductscience.org/library/papers/32226511 | PubMed |
| 15 | 31915377 | TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. | Nature | 2020 | https://conductscience.org/library/papers/31915377 | PubMed |
| 16 | 39859458 | Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859458 | PubMed |
| 17 | 39990663 | N6-methyladenosine Reader IGF2BP2-modified HMMR Promotes Non-small Cell Lung Cancer Metastasis via Interaction with MAP4K4. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/39990663 | PubMed |
| 18 | 37979378 | Advances and challenges in the treatment of lung cancer. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37979378 | PubMed |
| 19 | 39499616 | USP7 deubiquitinates KRAS and promotes non-small cell lung cancer. | Cell Rep | 2024 | https://conductscience.org/library/papers/39499616 | PubMed |
| 20 | 40016178 | PSMD14-mediated deubiquitination of CARM1 facilitates the proliferation and metastasis of hepatocellular carcinoma by inducing the transcriptional activation of FERMT1. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40016178 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42729688 | PSMD14 as a translational target in cancer and beyond: from deubiquitination mechanisms to drug resistance and precision therapy. | Cancer Drug Resist | 2026 | https://conductscience.org/library/papers/42729688 | PubMed |
| 42445433 | Prognostic and therapeutic implications of PSMD14 in hepatocellular carcinoma: an integrative analysis of transcriptomic and single-cell profiles. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445433 | PubMed |
| 42323743 | Expression of PIEZO1 in lung adenocarcinoma correlates with PD-L1 expression, cell migration, and poor prognosis: an exploratory study. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42323743 | PubMed |
| 42290188 | PDIA1 promotes androgen receptor activation and prostate cancer cell survival through enhancing HMMR stability. | FEBS Lett | 2026 | https://conductscience.org/library/papers/42290188 | PubMed |
| 42262718 | PSMD4 promotes malignant phenotypes and is associated with angiogenesis-related signaling and immune remodeling in hepatocellular carcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42262718 | PubMed |
| 42021279 | ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42021279 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| HMMR | 3161 | PubTator's text mining | https://conductscience.org/library/genes/3161 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| PSMD14 | 10213 | PubTator's text mining | https://conductscience.org/library/genes/10213 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41488674
GET https://conductscience.org/api/papers/v1/41488674/references?page=2